Xechem Intl. (fka ZKEM)

[jmhollen]

News Flash: Pharmaceutical and Nutraceutical Company
Making Waves with Cancer Drug Compounds
-- ZKEM Receives $1.15 Mil. in Additional Funding
Stock Still Trades at 0.8 cents/share!!

Many of Today's Most Widely Prescribed Drugs Rely on Compounds Found in Nature. ZKEM Isolates Those Compounds and Aims at Bringing Them to Market. ZKEM's Stock is Priced at 0.8 Cents - A Mere 3.2 Cent Increase in Stock Price Would Produce a 400% Return on Investment!

Today's profiled company, Xechem International, Inc. (OTCBB: ZKEM) is trading at only 0.8 cents/share. We ask: Which is easier - for a 0.8 cent stock to go to 8 cents or an $8 stock to explode tenfold to $80?

This is exactly why percentage changes with these types of <1 cent stocks can sometimes be phenomenal. If you bought one million shares of ZKEM at its current price and the stock moved up to just 4 cents a share, your $8,000 investment would grow to $40,000, representing a 400% gross profit!

Can ZKEM move to 4 cents, or even $4 a share in the long run? Maybe. The company's business model is very interesting and investors are starting to pay attention. In fact, ZKEM announced yesterday that it has received over $1.1 million in additional funding to further accelerate its development programs.

Accredited investors don't just invest $1.1 million without researching the company and its industry very thoroughly. That's why ZKEM's recent round of funding demonstrates that its investors must believe in the company's future. This is great news to all ZKEM investors!

Company:

ZKEM is a fully integrated pharmaceutical and nutraceutical company, providing generic and proprietary drugs for tomorrow's marketplace. The company is engaged in the research, development and production of generic and proprietary drugs from natural sources. It specializes in the development of niche-generic, difficult to replicate anticancer, antiviral (including Human Immunodeficiency Virus, HIV) and anti-fungal compounds.

ZKEM also screens extracts and pure compounds from various parts of the world, including China, India and Nigeria for their therapeutic use.

Plants and herbs have long been recognized and used for their therapeutic benefit. As a matter of fact, the World Health Organization (WHO) estimates that nearly 80% of the world's population relies on "Traditional Herbal Remedies" as a primary source of health care.

Approximately one fourth of all prescription drugs used in the U.S. alone contain pure compounds based upon molecules originally isolated from plants. The quest to discover these compounds in a variety of medicinal plants, marine sources and fermentation processes is one of ZKEM's top priorities.